ANGO PE Ratio & Valuation,Is ANGO Overvalued

ANGO Relative Valuation

ANGO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ANGO is overvalued; if below, it's undervalued.

Historical Valuation

AngioDynamics Inc (ANGO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -104.51. The fair price of AngioDynamics Inc (ANGO) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：13.34

Fair

-54.07

73.70

EV/EBITDA

AngioDynamics Inc. (ANGO) has a current EV/EBITDA of 73.70. The 5-year average EV/EBITDA is -6.34. The thresholds are as follows: Strongly Undervalued below -376.66, Undervalued between -376.66 and -191.50, Fairly Valued between 178.82 and -191.50, Overvalued between 178.82 and 363.98, and Strongly Overvalued above 363.98. The current Forward EV/EBITDA of 73.70 falls within the Historic Trend Line -Fairly Valued range.

-36.92

EV/EBIT

AngioDynamics Inc. (ANGO) has a current EV/EBIT of -36.92. The 5-year average EV/EBIT is 284.06. The thresholds are as follows: Strongly Undervalued below -2136.33, Undervalued between -2136.33 and -926.14, Fairly Valued between 1494.25 and -926.14, Overvalued between 1494.25 and 2704.45, and Strongly Overvalued above 2704.45. The current Forward EV/EBIT of -36.92 falls within the Historic Trend Line -Fairly Valued range.

1.72

AngioDynamics Inc. (ANGO) has a current PS of 1.72. The 5-year average PS is 1.78. The thresholds are as follows: Strongly Undervalued below 0.07, Undervalued between 0.07 and 0.92, Fairly Valued between 2.64 and 0.92, Overvalued between 2.64 and 3.49, and Strongly Overvalued above 3.49. The current Forward PS of 1.72 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

AngioDynamics Inc. (ANGO) has a current P/OCF of 0.00. The 5-year average P/OCF is -17.69. The thresholds are as follows: Strongly Undervalued below -357.76, Undervalued between -357.76 and -187.73, Fairly Valued between 152.34 and -187.73, Overvalued between 152.34 and 322.38, and Strongly Overvalued above 322.38. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

AngioDynamics Inc. (ANGO) has a current P/FCF of 0.00. The 5-year average P/FCF is -8.35. The thresholds are as follows: Strongly Undervalued below -92.11, Undervalued between -92.11 and -50.23, Fairly Valued between 33.54 and -50.23, Overvalued between 33.54 and 75.42, and Strongly Overvalued above 75.42. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

AngioDynamics Inc (ANGO) has a current Price-to-Book (P/B) ratio of 3.09. Compared to its 3-year average P/B ratio of 1.48 , the current P/B ratio is approximately 108.65% higher. Relative to its 5-year average P/B ratio of 1.69, the current P/B ratio is about 83.11% higher. AngioDynamics Inc (ANGO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -5.29%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -3.35% , the current FCF yield is about -100.00% lower.

3.09

P/B

Median3y

1.48

Median5y

1.69

-3.25

FCF Yield

Median3y

-5.29

Median5y

-3.35

Competitors Valuation Multiple

The average P/S ratio for ANGO's competitors is , providing a benchmark for relative valuation. AngioDynamics Inc Corp (ANGO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 12.18%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of ANGO increased by 45.63% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -10.81 to -17.03.

The secondary factor is the Revenue Growth, contributed 12.18%to the performance.

Overall, the performance of ANGO in the past 1 year is driven by P/E Change. Which is more unsustainable.

12.18%

67.49M → 75.71M

Revenue Growth

-24.05%

-18.96 → -14.40

Margin Expansion

57.50%

-10.81 → -17.03

P/E Change

45.63%

9.16 → 13.34

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is AngioDynamics Inc (ANGO) currently overvalued or undervalued?

What is AngioDynamics Inc (ANGO) fair value?

ANGO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of AngioDynamics Inc (ANGO) is between NaN to NaN according to relative valuation methord.

How does ANGO's valuation metrics compare to the industry average?

What is the current P/B ratio for AngioDynamics Inc (ANGO) as of Dec 16 2025?

As of Dec 16 2025, AngioDynamics Inc (ANGO) has a P/B ratio of 3.09. This indicates that the market values ANGO at 3.09 times its book value.

What is the current FCF Yield for AngioDynamics Inc (ANGO) as of Dec 16 2025?

As of Dec 16 2025, AngioDynamics Inc (ANGO) has a FCF Yield of 0.00%. This means that for every dollar of AngioDynamics Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for AngioDynamics Inc (ANGO) as of Dec 16 2025?

As of Dec 16 2025, AngioDynamics Inc (ANGO) has a Forward P/E ratio of -54.07. This means the market is willing to pay $-54.07 for every dollar of AngioDynamics Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for AngioDynamics Inc (ANGO) as of Dec 16 2025?

As of Dec 16 2025, AngioDynamics Inc (ANGO) has a Forward P/S ratio of 0.00. This means the market is valuing ANGO at $0.00 for every dollar of expected revenue over the next 12 months.

ANGO Valuation